Publications by authors named "David X M Zhao"

Claim this Profile
R
Redo-aortic valve replacement in prior stentless prosthetic aortic valves: Transcatheter versus surgical approach.
Charles H Choi, Kevin Cao, Diego Malaver, Edward H Kincaid, Adrian Lata, David X M Zhao

Catheter Cardiovasc Interv· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel technique for postclosure of large-bore sheaths using two Perclose devices.
Charles H Choi, James Kevin Hall, Diego Malaver, Robert J Applegate, David X M Zhao

Catheter Cardiovasc Interv· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of valve-in-valve transcatheter aortic valve replacement in failed stentless versus stented surgical bioprosthetic aortic valves.
Charles H Choi, Vivian Cheng, Diego Malaver, Neal Kon, Edward H Kincaid, David X M Zhao

Catheter Cardiovasc Interv· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of paravalvular aortic leak characteristics in the Medtronic CoreValve versus Edwards Sapien Valve: Paravalvular aortic leak characteristics.
Olivia N Gilbert, Charles H Choi, Jodie L Franzil, Melissa Caughey, Waqas Qureshi, David X M Zhao

Catheter Cardiovasc Interv· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis.
Jay H Traverse, Timothy D Henry, Carl J Pepine, James T Willerson, Atul Chugh, David X M Zhao

Circ Res· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Bone Marrow Cell Subpopulations Associated With Improved Functional Outcomes in Patients With Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial.
Doris A Taylor, Emerson C Perin, James T Willerson, Claudia Zierold, Micheline Resende, David X M Zhao

Cell Transplant· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial.
Aruni Bhatnagar, Roberto Bolli, Brian H Johnstone, Jay H Traverse, Timothy D Henry, David X M Zhao

Am Heart J· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial.
Robert C Schutt, Barry H Trachtenberg, John P Cooke, Jay H Traverse, Timothy D Henry, David X M Zhao

Circ Res· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes.
Christopher R Cogle, Elizabeth Wise, Amy M Meacham, Claudia Zierold, Jay H Traverse, David X M Zhao

Circ Res· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.
Jay H Traverse, Timothy D Henry, Carl J Pepine, James T Willerson, David X M Zhao

JAMA· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.
Emerson C Perin, James T Willerson, Carl J Pepine, Timothy D Henry, Stephen G Ellis, David X M Zhao

JAMA· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.
Jay H Traverse, Timothy D Henry, Stephen G Ellis, Carl J Pepine, James T Willerson, David X M Zhao

JAMA· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction.
Jay H Traverse, Timothy D Henry, Douglas E Vaughan, Stephen G Ellis, Carl J Pepine, David X M Zhao

Tex Heart Inst J· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and design.
James T Willerson, Emerson C Perin, Stephen G Ellis, Carl J Pepine, Timothy D Henry, David X M Zhao

Am Heart J· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a network to test strategies in cardiovascular cell delivery: the NHLBI-sponsored Cardiovascular Cell Therapy Research Network (CCTRN).
Robert D Simari, Lemuel A Moyé, Sonia I Skarlatos, Stephen G Ellis, David X M Zhao

J Cardiovasc Transl Res· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction.
Jay H Traverse, Timothy D Henry, Douglas E Vaughan, Stephen G Ellis, Carl J Pepine, David X M Zhao

Am Heart J· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of unprotected left main coronary artery stenosis in a 5-year-old heart transplant patient using a sirolimus-eluting stent.
Joseph G Salloum, Debra A Dodd, David Slosky, David X M Zhao

J Heart Lung Transplant· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis